#Pharma #Santé galénique génériques et prix Pay-for-delay deals lead to inflated drug prices says study - PMLiVE http://t.co/BEOb8ti7jj
June 21, 2013
Publicité
/http%3A%2F%2Fwww.pmlive.com%2F__data%2Fassets%2Fimage%2F0010%2F409357%2FAdderall-XR---Shire-ADHD-body.jpg)
Pay-for-delay deals lead to inflated drug prices says study
Payments from a branded drug manufacturer to a generic maker to delay market entry can lead to broadly inflated prices across a therapeutic category, according to new research. The findings suggest that efforts to investigate and ban pay-for-delay deals are justified, says study author UK health economist Dr Farosat Bokhari from the University of East Anglia.